AMA CXO Todd Unger reviews the latest on vaccines for children ages 6 months through 4 years, as well as boosters for 5-11 year olds with AMA Director of Science, Medicine and Public Health, Andrea Garcia, JD, MPH. Also covering CDC’s recommendation on a second booster shot for people 50 or older, and the latest on the monkeypox outbreak.
Read MoreAMA CXO Todd Unger reviews the latest timeline on Moderna and Pfizer vaccine authorizations for young children with AMA Director of Science, Medicine and Public Health, Andrea Garcia. Also covering the rise in COVID cases, FDA’s proposed timing to review data on Novavax and variant-specific vaccines, as well as how to spot fake COVID-19 at-home tests.
Read MoreAMA CXO Todd Unger reviews COVID-19 case numbers and the legal battle over mask mandates with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the CDC’s latest health alert for COVID therapies, as well as the FDA’s approval of Remdesivir to treat pediatric coronavirus patients (kids 12 and younger).
More information on the CDC’s health alert: https://emergency.cdc.gov/han/2022/han00463.asp
Read MoreAMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering state-wide mandates lifting for masks in school, and the latest developments on when a COVID vaccine will be available for kids under 5.
Read MoreAMA CXO Todd Unger reviews COVID-19 case numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the government’s newly released COVID response strategy and how it will take the nation out of crisis mode, the CDC’s scaled back contact tracing efforts and the U.S. Surgeon General’s renewed push to fight misinformation online.
Read MoreAMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the latest on coronavirus treatments, including Merk’s COVID pill, as well as research outlining the positive effects of getting vaccinated during pregnancy.
Read MoreAMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia, JD, MPH. Also covering the World Health Organization’s (WHO) opinion on life post-Omicron, as well as newly published data from the CDC, JAMA, and what that research means in the battle against the current U.S. COVID surge. Additionally, the FDA has revised authorizations for two monoclonal antibody treatments—a topic AMA’s immediate past-president, Susan Bailey, MD, will be discussing in an upcoming webinar with experts from the FDA.
Read MoreAMA CXO Todd Unger reviews rising COVID-19 case numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also detailing what physicians and patients need to know about the CDC’s updated guidance on isolation, quarantine and testing.
Read MoreAMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the latest on COVID-19 treatment pills, expanding eligibility for booster shots, what the uptick in cases in Europe could forecast for the U.S., as well as flu outbreaks and press releases from the November 2021 Special Meeting of the AMA House of Delegates.
Read MoreAMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the FDA’s authorization of Pfizer-BioNTech’s coronavirus vaccine for emergency use in children 5 to 11, vaccine mandates in schools, and the AMA’s support of the Biden Administration’s plan to address the nation’s overdose epidemic.
Read More
Comentarios recientes